PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Hikma Pharmaceuticals International Ltd
HP

Hikma Pharmaceuticals International Ltd

London
Large

Hikma Pharmaceuticals International Ltd is a global pharmaceutical company that specializes in the development, manufacturing, and marketing of a broad range of generic and branded pharmaceuticals. They are committed to advancing health and wellbeing through their products and services.

hikma.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£482.9m
Live
6
Buyers
4
12m
£482.9m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts6 / 11
  • Top buyers4
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Hikma Pharmaceuticals International LtdUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Hikma Pharmaceuticals International Ltd has won £482.9m across 4 public-sector buyers, with 6 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 95% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
6 of 11Live contracts
95%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value · 1/5

Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.

◐ From supplier website
JobsNo commitment stated✓
SkillsNo commitment stated✓
EnvironmentNo commitment stated✓
Tackling inequalityNo commitment stated✓
Community1 commitment ↗✓
Community · 1
  • WebsiteAdvancing health and wellbeingHikma is dedicated to improving access to medicines and ensuring product quality and safety.

Extracted automatically from hikma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 2
Contract manufacturingHikma offers contract manufacturing services including injectables and Hikma Rx contract manufacturing. ↗Hikma VenturesHikma Ventures focuses on investing in innovative healthcare companies. ↗

Extracted automatically from hikma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 6 live · 5 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Transitional Drugs 7
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£16.8m2 yrspending
NHS National Generics Pharmaceuticals - Supply Chain Resilience
NHS England—01 Sept 2026£35.0m1.8 yrspending
Generic Drugs – Injections/Infusions 2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£5.9m12 mopending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS National Framework for Generics Housekeeping
NHS England—01 Feb 2026£21.6m1.7 yrspending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England————Live
NHS National Framework for Generics Housekeeping
NHS England————Live
NP35925 Cardiovascular & Respiratory Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)33600000———Live
Transitional Drugs 7
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)————Live
Generic Drugs – Injections/Infusions 2
NHS Wales Shared Service Partnership————Live
Total live value — · mean award £43.9m1–10 of 11

Top buyers · 4 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
6 contracts
95%
since 2025
2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
3 contracts
5%
since 2026
3
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
1 contract
0%
4
NHS Wales Shared Service Partnership
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire6 contracts
95%
Wales4 contracts
5%
Scotland1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Hikma Pharmaceuticals International Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
HP
Hikma Pharmaceuticals International Ltd
No£482.9m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 15 Sept 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
07680243
Status
Active
Type
Private limited
Incorporated
23 Jun 2011
Reg. office
1 New Burlington Place, London, W1S 2HR
SIC codes
21100
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • VERISSIMO, Goncalo Pina Pereira — director
    Appointed 25 Mar 2025
  • AL KURDI, Areb — director
    Appointed 15 Aug 2022
  • MIDDLEMIST, Helen — secretary
    Appointed 18 Jul 2022
  • Hikma Uk Limited — person with significant control
    ownership of shares 75 to 100 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
HIKMA PHARMACEUTICALS INTERNATIONAL LIMITED
07680243 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.